Zacks Research Has Negative View of Palomar FY2028 Earnings

Posted by on Aug 4th, 2026

Palomar Holdings, Inc. (NASDAQ:PLMR – Free Report) – Analysts at Zacks Research cut their FY2028 EPS estimates for Palomar in a note issued to investors on Monday, August 3rd. Zacks Research analyst Team now anticipates that the company will post earnings per share of $10.45 for the year, down from their previous forecast of $10.62. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Palomar’s current full-year earnings is $8.90 per share.

Palomar (NASDAQ:PLMR – Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $2.31 EPS for the quarter, beating the consensus estimate of $2.17 by $0.14. Palomar had a net margin of 20.11% and a return on equity of 22.62%. The business had revenue of $278.94 million during the quarter, compared to the consensus estimate of $557.79 million. During the same quarter in the prior year, the firm earned $1.87 EPS. The firm’s quarterly revenue was up 59.7% on a year-over-year basis.

Several other research firms have also recently weighed in on PLMR. JPMorgan Chase & Co. lifted their target price on Palomar from $150.00 to $167.00 and gave the company an “overweight” rating in a research note on Monday, July 20th. Evercore set a $152.00 price objective on shares of Palomar in a research note on Friday, July 10th. Keefe, Bruyette & Woods increased their target price on shares of Palomar from $162.00 to $166.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 8th. Piper Sandler boosted their price target on shares of Palomar from $132.00 to $165.00 and gave the company an “overweight” rating in a report on Wednesday, July 15th. Finally, Weiss Ratings upgraded Palomar from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, June 18th. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, Palomar currently has a consensus rating of “Moderate Buy” and a consensus target price of $162.50.

Read Our Latest Analysis on Palomar

Palomar Price Performance

PLMR opened at $136.51 on Tuesday. Palomar has a 12-month low of $100.81 and a 12-month high of $147.62. The company has a quick ratio of 0.49, a current ratio of 0.49 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $3.62 billion, a P/E ratio of 19.01 and a beta of 0.40. The stock has a fifty day moving average of $124.76 and a 200-day moving average of $123.54.

Insider Activity

In related news, insider Timothy Carter sold 480 shares of Palomar stock in a transaction on Sunday, June 28th. The shares were sold at an average price of $124.29, for a total value of $59,659.20. Following the completion of the sale, the insider owned 1,670 shares of the company’s stock, valued at approximately $207,564.30. The trade was a 22.33% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Mac Armstrong sold 3,500 shares of the company’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $112.96, for a total transaction of $395,360.00. Following the completion of the sale, the chief executive officer owned 329,388 shares of the company’s stock, valued at $37,207,668.48. This represents a 1.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 20,843 shares of company stock worth $2,711,683. 3.70% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Geneos Wealth Management Inc. acquired a new stake in Palomar in the 4th quarter worth approximately $32,000. Kestra Advisory Services LLC acquired a new position in Palomar during the fourth quarter valued at approximately $33,000. Rockefeller Capital Management L.P. grew its holdings in Palomar by 81.5% during the fourth quarter. Rockefeller Capital Management L.P. now owns 294 shares of the company’s stock valued at $40,000 after purchasing an additional 132 shares during the last quarter. Parallel Advisors LLC raised its position in shares of Palomar by 638.3% in the first quarter. Parallel Advisors LLC now owns 443 shares of the company’s stock valued at $53,000 after purchasing an additional 383 shares during the period. Finally, Frazier Financial Advisors LLC bought a new position in shares of Palomar in the fourth quarter valued at approximately $54,000. Institutional investors and hedge funds own 90.25% of the company’s stock.

Palomar Company Profile

(Get Free Report)

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.

Read More

Earnings History and Estimates for Palomar (NASDAQ:PLMR)

Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.